ID: ALA4165398

Max Phase: Preclinical

Molecular Formula: C16H18N4S

Molecular Weight: 298.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1cnc2c(n1)Nc1cc(CN3CCCCC3)ccc1S2

Standard InChI:  InChI=1S/C16H18N4S/c1-2-8-20(9-3-1)11-12-4-5-14-13(10-12)19-15-16(21-14)18-7-6-17-15/h4-7,10H,1-3,8-9,11H2,(H,17,19)

Standard InChI Key:  WWRHILXBHOPSDB-UHFFFAOYSA-N

Associated Targets(Human)

Intercellular adhesion molecule-1 260 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.42Molecular Weight (Monoisotopic): 298.1252AlogP: 3.67#Rotatable Bonds: 2
Polar Surface Area: 41.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.84CX Basic pKa: 8.21CX LogP: 3.17CX LogD: 2.30
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.78Np Likeness Score: -1.29

References

1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E..  (2017)  Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.,  138  [PMID:28734245] [10.1016/j.ejmech.2017.07.009]

Source